200 related articles for article (PubMed ID: 15379759)
1. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Osaki M; Moriyama M; Adachi K; Nakada C; Takeda A; Inoue Y; Adachi H; Sato K; Oshimura M; Ito H
Eur J Clin Invest; 2004 Sep; 34(9):605-12. PubMed ID: 15379759
[TBL] [Abstract][Full Text] [Related]
2. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
3. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
5. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1.
Nagahama Y; Ishimaru M; Osaki M; Inoue T; Maeda A; Nakada C; Moriyama M; Sato K; Oshimura M; Ito H
Cancer Sci; 2008 Jan; 99(1):23-30. PubMed ID: 17956589
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
8. Growth regulation of gastric epithelial cells by Runx3.
Fukamachi H; Ito K
Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
[TBL] [Abstract][Full Text] [Related]
9. In vitro differentiation of Runx3-/- p53-/- gastric epithelial cells into intestinal type cells.
Fukamachi H; Mimata A; Tanaka I; Ito K; Ito Y; Yuasa Y
Cancer Sci; 2008 Apr; 99(4):671-6. PubMed ID: 18377419
[TBL] [Abstract][Full Text] [Related]
10. [Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer].
Wu BW; Zhang J; Fei XF; Zhu ZG; Cao WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):165-8. PubMed ID: 17380460
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
13. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
[TBL] [Abstract][Full Text] [Related]
14. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
15. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 3 expression in human oral squamous cell carcinomas; implication for tumor progression and prognosis.
Tanji Y; Osaki M; Nagahama Y; Kodani I; Ryoke K; Ito H
Oral Oncol; 2007 Jan; 43(1):88-94. PubMed ID: 16798064
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
18. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas.
Carvalho R; Milne AN; Polak M; Corver WE; Offerhaus GJ; Weterman MA
Oncogene; 2005 Dec; 24(56):8252-8. PubMed ID: 16091737
[TBL] [Abstract][Full Text] [Related]
19. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma.
Li XL; Eishi Y; Bai YQ; Sakai H; Akiyama Y; Tani M; Takizawa T; Koike M; Yuasa Y
Int J Oncol; 2004 Feb; 24(2):257-63. PubMed ID: 14719100
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT.
Gulmann C; Lantuejoul S; Grace A; Leader M; Patchett S; Kay E
Dig Liver Dis; 2005 Jun; 37(6):439-45. PubMed ID: 15893283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]